Fermenta Biotech Limited (BOM:506414)
India flag India · Delayed Price · Currency is INR
447.05
+30.40 (7.30%)
At close: Nov 6, 2026

Fermenta Biotech Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
505.61717.65768.62-230.6-510.75154.47
Depreciation & Amortization
207.95216.1240.87244.55277.83248.84
Other Amortization
0.870.871.312.654.646.78
Loss (Gain) From Sale of Assets
1.03-1.0570.17381.26447.580.27
Stock-Based Compensation
42.6729.53-1.91-10.1926.97
Provision & Write-off of Bad Debts
43.3537.4811.728.565314.47
Other Operating Activities
5.3911.8699.94318.1449.45156.41
Change in Accounts Receivable
69.99-93.28-341.58-339.48353.07-170.17
Change in Inventory
-183.86-167.46-321.27427.5699.3127.94
Change in Accounts Payable
253.25109.33137.9243.19-152.7131.3
Change in Other Net Operating Assets
149.5967.31-258.66-4.23149.85-62.85
Operating Cash Flow
1,096928.34409.021,0531,161434.41
Operating Cash Flow Growth
33.19%126.97%-61.17%-9.27%167.28%-30.60%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-352.28-303.35-221.33-192.07-404.89-371.28
Sale of Property, Plant & Equipment
0.331.09192.510.650.460.91
Investment in Securities
-94.22-167.78-50.9740.34-163.938.81
Other Investing Activities
29.8440.0778.2-3.914.2571.19
Investing Cash Flow
-416.62-429.96-1.6-154.97-554.09-260.38

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-122.09--22.915.97
Long-Term Debt Issued
-4.3-30.54363.08243.05
Total Debt Issued
11.38126.39-30.54386249.02
Short-Term Debt Repaid
---24.8-218.15--
Long-Term Debt Repaid
--193.36-347.94-518.17-552.37-225.96
Lease Payments
-15.24-14.87-14.5-13.39-12.79-13.66
Total Debt Repaid
-313.19-193.36-372.74-736.32-552.37-225.96
Net Debt Issued (Repaid)
-301.82-66.96-372.74-705.79-166.3723.06
Issuance of Common Stock
4.810.0724.67---
Repurchase of Common Stock
-148.2-172.82----
Common Dividends Paid
-107.55-72.92-36.12-36.09-42-72.12
Other Financing Activities
-117.12-110.25-124.47-166.64-205.43-166.73
Financing Cash Flow
-669.88-422.89-508.66-908.52-413.8-215.78

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
---0-0.49-
Net Cash Flow
9.3275.49-101.23-10.03193.69-41.75

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
743.55624.99187.69861.39756.1963.13
Free Cash Flow Growth
41.24%233.00%-78.21%13.91%1097.83%-13.83%
Free Cash Flow Margin
14.67%11.89%4.00%25.66%21.61%1.58%
Free Cash Flow Per Share
25.4421.356.4329.8326.202.18
Levered Free Cash Flow
-453.55-646.5610.22158.24528.43-163.2
Unlevered Free Cash Flow
-377.77-574.4598.92264.78658.32-61.52
Free Cash Flow After Leases
728.31610.12173.19848743.449.47

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
110.25110.25124.47166.64205.43166.73
Cash Income Tax Paid
164.21164.2127.71-10.18-32.0893.08
Change in Working Capital
288.97-84.1-783.62327.04449.52-173.78